On the public citation graph

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

https://doi.org/10.1128/cvi.00278-10
0 signed · 211 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.283.4.499openalex-snapshot
Impact of Respiratory Virus Infections on Persons With Chronic Underlying Conditions
inferredcites →https://doi.org/10.1002/jmv.20288openalex-snapshot
New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia
inferredcites →https://doi.org/10.1016/j.jcv.2005.09.008openalex-snapshot
Evidence of human coronavirus HKU1 and human bocavirus in Australian children
inferredcites →https://doi.org/10.1016/j.jcv.2007.08.007openalex-snapshot
Seroepidemiology of group I human coronaviruses in children
inferredcites →https://doi.org/10.1016/j.jmb.2006.09.074openalex-snapshot
Mosaic Structure of Human Coronavirus NL63, One Thousand Years of Evolution
inferredcites →https://doi.org/10.1016/j.jpeds.2007.10.043openalex-snapshot
Respiratory Viruses in Laryngeal Croup of Young Children
inferredcites →https://doi.org/10.1016/j.jviromet.2006.09.024openalex-snapshot
Baculovirus expression of HCoV-OC43 nucleocapsid protein and development of a Western blot assay for detection of human antibodies against HCoV-OC43
inferredcites →https://doi.org/10.1016/s0264-410x(02)00748-xopenalex-snapshot
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study
inferredcites →https://doi.org/10.1016/s0895-4356(03)00171-9openalex-snapshot
A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection
inferredcites →https://doi.org/10.1017/s0022172400062410openalex-snapshot
Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection
inferredcites →https://doi.org/10.1017/s0950268800048019openalex-snapshot
The time course of the immune response to experimental coronavirus infection of man
inferredcites →https://doi.org/10.1038/nature03712openalex-snapshot
Angiotensin-converting enzyme 2 protects from severe acute lung failure
inferredcites →https://doi.org/10.1038/nm1024openalex-snapshot
Identification of a new human coronavirus
inferredcites →https://doi.org/10.1038/nrmicro2147openalex-snapshot
Coronaviruses post-SARS: update on replication and pathogenesis
inferredcites →https://doi.org/10.1056/nejm197503132921105openalex-snapshot
Role of Infection in Chronic Bronchitis
inferredcites →https://doi.org/10.1056/nejmra032498openalex-snapshot
The Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1073/pnas.0400762101openalex-snapshot
A previously undescribed coronavirus associated with respiratory disease in humans
inferredcites →https://doi.org/10.1086/313937openalex-snapshot
Spectrum of Clinical Illness in Hospitalized Patients with "Common Cold" Virus Infections
inferredcites →https://doi.org/10.1086/339881openalex-snapshot
Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older Adults
inferredcites →https://doi.org/10.1086/374222openalex-snapshot
An Outbreak of Coronavirus OC43 Respiratory Infection in Normandy, France
inferredcites →https://doi.org/10.1086/381207openalex-snapshot
Frequent Detection of Human Coronaviruses in Clinical Specimens from Patients with Respiratory Tract Infection by Use of a Novel Real‐Time Reverse‐Transcriptase Polymerase Chain Reaction
inferredcites →https://doi.org/10.1086/421121openalex-snapshot
Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1086/426869openalex-snapshot
Human Coronavirus NL63 Infection in Canada
inferredcites →https://doi.org/10.1086/428138openalex-snapshot
Evidence of a Novel Human Coronavirus That Is Associated with Respiratory Tract Disease in Infants and Young Children
inferredcites →https://doi.org/10.1086/430301openalex-snapshot
Human Coronavirus NL63 Infection and Other Coronavirus Infections in Children Hospitalized with Acute Respiratory Disease in Hong Kong, China
inferredcites →https://doi.org/10.1086/497151openalex-snapshot
Clinical and Molecular Epidemiological Features of Coronavirus HKU1–Associated Community‐Acquired Pneumonia
inferredcites →https://doi.org/10.1086/507898openalex-snapshot
A Prospective Hospital‐Based Study of the Clinical Impact of Non–Severe Acute Respiratory Syndrome (Non‐SARS)–Related Human Coronavirus Infection
inferredcites →https://doi.org/10.1086/521308openalex-snapshot
Human Coronavirus Infections in Rural Thailand: A Comprehensive Study Using Real‐Time Reverse‐Transcription Polymerase Chain Reaction Assays
inferredcites →https://doi.org/10.1086/597122openalex-snapshot
Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1093/infdis/129.3.271openalex-snapshot
The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection
inferredcites →https://doi.org/10.1093/infdis/173.2.285openalex-snapshot
Induction of Mucosal Antibodies by Live Attenuated and Inactivated Influenza Virus Vaccines in the Chronically III Elderly
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a114315openalex-snapshot
RISES IN TITERS OF ANTIBODY TO HUMAN CORONA VIRUSES OC43 AND 229E IN SEATTLE FAMILIES DURING 1975–1979
inferredcites →https://doi.org/10.1128/cvi.00124-08openalex-snapshot
Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population
inferredcites →https://doi.org/10.1128/iai.32.3.1216-1226.1981openalex-snapshot
Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells
inferredcites →https://doi.org/10.1128/jcm.00533-08openalex-snapshot
Human Coronavirus NL63 and 229E Seroconversion in Children
inferredcites →https://doi.org/10.1128/jcm.02614-05openalex-snapshot
Coronavirus HKU1 and Other Coronavirus Infections in Hong Kong
inferredcites →https://doi.org/10.1128/jvi.01466-06openalex-snapshot
The Novel Human Coronaviruses NL63 and HKU1
inferredcites →https://doi.org/10.1128/jvi.79.2.884-895.2005openalex-snapshot
Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia
inferredcites →https://doi.org/10.1164/ajrccm.162.1.9911019openalex-snapshot
Respiratory Viral Infections in Adults With and Without Chronic Obstructive Pulmonary Disease
inferredcites →https://doi.org/10.1371/journal.pmed.0020240openalex-snapshot
Croup Is Associated with the Novel Coronavirus NL63
inferredcites →https://doi.org/10.1542/peds.2006-1406openalex-snapshot
Clinical Disease in Children Associated With Newly Described Coronavirus Subtypes
inferredcites →https://doi.org/10.3201/eid1108.050110openalex-snapshot
Human Coronavirus NL63, France
inferredcites →https://doi.org/10.3201/eid1205.051316openalex-snapshot
Coronavirus HKU1 Infection in the United States
inferredcites →https://doi.org/10.3201/eid1602.090469openalex-snapshot
Effects of Coronavirus Infections in Children
inferredcites →https://doi.org/10.4183/aeb.2005.499openalex-snapshot
Harrison's Principles of Internal Medicine 16th ed
inferredcites →https://doi.org/10.7326/0003-4819-108-3-499_2openalex-snapshot
Harrison's Principles of Internal Medicine.

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3622324openalex-extracted
The COVID-19 Pandemic: Diverse Contexts; Different Epidemics—How and Why?
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0093openalex-snapshot
Coronaviruses
inferred← citeshttps://doi.org/10.1002/9781683674849.mcm0093openalex-snapshot
Coronaviruses
inferred← citeshttps://doi.org/10.1002/iid3.70463openalex-snapshot
Widespread SARS‐CoV‐2 Transmission Despite Limited Reported Cases and Clinical Disease: Exploring the Role of Pre‐Existing Humoral Immunity to SARS‐CoV‐2 in Eastern Sierra Leone
inferred← citeshttps://doi.org/10.1002/jmv.24780openalex-snapshot
Interpatient mutational spectrum of human coronavirus‐OC43 revealed by illumina sequencing
inferred← citeshttps://doi.org/10.1002/jmv.25715openalex-snapshot
Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses
inferred← citeshttps://doi.org/10.1002/jmv.26009openalex-snapshot
Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
inferred← citeshttps://doi.org/10.1002/jmv.26628openalex-snapshot
Unexpected high frequency of unspecific reactivities by testing pre‐epidemic blood specimens from Europe and Africa with SARS‐CoV‐2 IgG–IgM antibody rapid tests points to IgM as the Achilles heel
inferred← citeshttps://doi.org/10.1007/978-1-4899-7448-8_10openalex-snapshot
Coronaviruses
inferred← citeshttps://doi.org/10.1007/978-1-4939-9544-8_67-1openalex-snapshot
Coronaviruses: The Common Cold, SARS, and MERS
inferred← citeshttps://doi.org/10.1007/s10096-020-04072-7openalex-snapshot
Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2
inferred← citeshttps://doi.org/10.1007/s10875-021-00997-6openalex-snapshot
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
inferred← citeshttps://doi.org/10.1007/s10995-020-02981-9openalex-snapshot
Using Prenatal Blood Samples to Evaluate COVID-19 Rapid Serologic Tests Specificity
inferred← citeshttps://doi.org/10.1007/s12035-020-02249-xopenalex-snapshot
Impact of COVID-19 in the Mental Health in Elderly: Psychological and Biological Updates
inferred← citeshttps://doi.org/10.1007/s42399-020-00634-0openalex-snapshot
Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19
inferred← citeshttps://doi.org/10.1016/b978-0-12-824494-4.00014-xopenalex-snapshot
Recent developments of molecular/biosensor diagnostics for SARS-CoV-2 detection
inferred← citeshttps://doi.org/10.1016/bs.ai.2021.08.002openalex-snapshot
Immunology of SARS-CoV-2 infections and vaccines
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113499openalex-snapshot
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
inferred← citeshttps://doi.org/10.1016/j.cell.2020.05.015openalex-snapshot
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
inferred← citeshttps://doi.org/10.1016/j.cell.2020.12.015openalex-snapshot
COVID-19 Neutralizing Antibodies Predict Disease Severity and Survival
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110904openalex-snapshot
IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes
inferred← citeshttps://doi.org/10.1016/j.clinbiochem.2021.01.010openalex-snapshot
Initial Determination of COVID-19 Seroprevalence Among Outpatients and Healthcare Workers in Minnesota Using a Novel SARS-CoV-2 Total Antibody ELISA
inferred← citeshttps://doi.org/10.1016/j.cll.2021.10.004openalex-snapshot
Antibody Dynamics and Durability in Coronavirus Disease-19
inferred← citeshttps://doi.org/10.1016/j.cll.2021.10.006openalex-snapshot
Performance Characteristics of High-Throughput Serologic Assays for Severe Acute Respiratory Syndrome Coronavirus 2 with Food and Drug Administration Emergency Use Authorization
inferred← citeshttps://doi.org/10.1016/j.cmi.2020.06.024openalex-snapshot
Validation of a commercially available SARS-CoV-2 serological immunoassay
inferred← citeshttps://doi.org/10.1016/j.coviro.2021.11.015openalex-snapshot
Immune responses to human respiratory coronaviruses infection in mouse models
inferred← citeshttps://doi.org/10.1016/j.diagmicrobio.2020.115161openalex-snapshot
Retrospective clinical evaluation of 4 lateral flow assays for the detection of SARS-CoV-2 IgG
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103700openalex-snapshot
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.11.044openalex-snapshot
Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China
inferred← citeshttps://doi.org/10.1016/j.ijid.2023.11.008openalex-snapshot
Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam
inferred← citeshttps://doi.org/10.1016/j.ijmmb.2021.03.008openalex-snapshot
Haemophilus influenzae and SARS-CoV-2: Is there a role for investigation?
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.07.005openalex-snapshot
Lessons for COVID-19 Immunity from Other Coronavirus Infections
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.10.004openalex-snapshot
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108020openalex-snapshot
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108187openalex-snapshot
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
inferred← citeshttps://doi.org/10.1016/j.isci.2023.107394openalex-snapshot
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis
inferred← citeshttps://doi.org/10.1016/j.jinf.2020.10.023openalex-snapshot
Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study
inferred← citeshttps://doi.org/10.1016/j.jviromet.2021.114111openalex-snapshot
Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses
inferred← citeshttps://doi.org/10.1016/j.molimm.2021.04.010openalex-snapshot
Non-human primate models of human respiratory infections
inferred← citeshttps://doi.org/10.1016/j.tim.2021.03.016openalex-snapshot
Durability of Immunity to SARS-CoV-2 and Other Respiratory Viruses
inferred← citeshttps://doi.org/10.1016/j.virol.2025.110512openalex-snapshot
Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1
inferred← citeshttps://doi.org/10.1016/j.virusres.2014.03.018openalex-snapshot
Serological assays for emerging coronaviruses: Challenges and pitfalls
inferred← citeshttps://doi.org/10.1016/j.xcrm.2020.100189openalex-snapshot
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses
inferred← citeshttps://doi.org/10.1016/j.xcrm.2021.100191openalex-snapshot
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
inferred← citeshttps://doi.org/10.1016/s2666-5247(20)30221-4openalex-snapshot
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015–20: a surveillance study
inferred← citeshttps://doi.org/10.1017/9781009396998.005openalex-snapshot
Immunology of COVID-19 and Ineffective Immunity
inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00725openalex-snapshot
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2
inferred← citeshttps://doi.org/10.1021/acsinfecdis.2c00086openalex-snapshot
Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2
inferred← citeshttps://doi.org/10.1021/acssensors.0c02621openalex-snapshot
COVID-19 Antibody Tests and Their Limitations
inferred← citeshttps://doi.org/10.1038/s41372-021-01001-0openalex-snapshot
Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43
inferred← citeshttps://doi.org/10.1038/s41385-022-00569-wopenalex-snapshot
Role of the humoral immune response during COVID-19: guilty or not guilty?
inferred← citeshttps://doi.org/10.1038/s41467-021-21856-3openalex-snapshot
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
inferred← citeshttps://doi.org/10.1038/s41467-021-23893-4openalex-snapshot
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41467-021-23977-1openalex-snapshot
Immunological imprinting of the antibody response in COVID-19 patients
inferred← citeshttps://doi.org/10.1038/s41467-023-41761-1openalex-snapshot
Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41467-024-45043-2openalex-snapshot
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
inferred← citeshttps://doi.org/10.1038/s41541-020-00248-6openalex-snapshot
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41577-020-0389-zopenalex-snapshot
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
inferred← citeshttps://doi.org/10.1038/s41586-020-03148-wopenalex-snapshot
Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
inferred← citeshttps://doi.org/10.1038/s41590-021-01122-wopenalex-snapshot
The T cell immune response against SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41598-023-35471-3openalex-snapshot
Coronavirus spike protein-specific antibodies indicate frequent infections and reinfections in infancy and among BNT162b2-vaccinated healthcare workers
inferred← citeshttps://doi.org/10.1042/bst20200744openalex-snapshot
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications
inferred← citeshttps://doi.org/10.1080/08998280.2022.2068940openalex-snapshot
COVID-19—from emerging global threat to ongoing pandemic crisis
inferred← citeshttps://doi.org/10.1080/21505594.2022.2073025openalex-snapshot
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
inferred← citeshttps://doi.org/10.1080/21645515.2021.1944742openalex-snapshot
Early approval of COVID-19 vaccines: Pros and cons
inferred← citeshttps://doi.org/10.1080/22221751.2021.1905488openalex-snapshot
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
inferred← citeshttps://doi.org/10.1080/22221751.2021.1994354openalex-snapshot
One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization
inferred← citeshttps://doi.org/10.1093/cid/ciac353openalex-snapshot
Clinical Validation of a Novel T-Cell Receptor Sequencing Assay for Identification of Recent or Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection
inferred← citeshttps://doi.org/10.1093/clinchem/hvaa107openalex-snapshot
SARS-CoV-2 Serology: Much Hype, Little Data
inferred← citeshttps://doi.org/10.1093/infdis/jiad430openalex-snapshot
Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells
inferred← citeshttps://doi.org/10.1093/oxfimm/iqac005openalex-snapshot
SARS-CoV-2 immunity and vaccine strategies in people with HIV
inferred← citeshttps://doi.org/10.1096/fj.202100024ropenalex-snapshot
Endothelial cell, myeloid, and adaptive immune responses in SARS‐CoV‐2 infection
inferred← citeshttps://doi.org/10.1101/2020.05.02.20080879openalex-snapshot
Validation of a commercially available SARS-CoV-2 serological Immunoassay
inferred← citeshttps://doi.org/10.1101/2020.09.01.20182220openalex-snapshot
Cross-reactive antibody responses against SARS-CoV-2 and seasonal common cold coronaviruses
inferred← citeshttps://doi.org/10.1101/2020.10.10.334292openalex-snapshot
The landscape of antibody binding in SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1101/2020.11.08.20227975openalex-snapshot
A model of endemic coronavirus infections
inferred← citeshttps://doi.org/10.1101/2021.04.29.441258openalex-snapshot
Allelic variation in Class I HLA determines pre-existing memory responses to SARS-CoV-2 that shape the CD8 + T cell repertoire upon viral exposure
inferred← citeshttps://doi.org/10.1101/2021.09.14.460338openalex-snapshot
Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
inferred← citeshttps://doi.org/10.1101/2022.06.01.494373openalex-snapshot
Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis
inferred← citeshttps://doi.org/10.1101/2022.07.26.501649openalex-snapshot
Age-related seroprevalence trajectories of seasonal coronaviruses in children
inferred← citeshttps://doi.org/10.1101/2025.08.03.668342openalex-snapshot
De novo identification of the specificities of recurrent human T cell receptors
inferred← citeshttps://doi.org/10.1126/sciadv.aeb1732openalex-snapshot
De novo identification of the specificities of recurrently identified human T cell receptors
inferred← citeshttps://doi.org/10.1126/science.abd3871openalex-snapshot
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
inferred← citeshttps://doi.org/10.1126/science.abd4250openalex-snapshot
Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
inferred← citeshttps://doi.org/10.1126/sciimmunol.abe9950openalex-snapshot
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers
inferred← citeshttps://doi.org/10.1126/sciimmunol.abk3070openalex-snapshot
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2.
inferred← citeshttps://doi.org/10.1128/9781555817381.ch90openalex-snapshot
Coronaviruses
inferred← citeshttps://doi.org/10.1128/jcm.00797-20openalex-snapshot
The Role of Antibody Testing for SARS-CoV-2: Is There One?
inferred← citeshttps://doi.org/10.1128/jcm.01029-20openalex-snapshot
Patients with Common Cold Coronaviruses Tested Negative for IgG Antibody to SARS-CoV-2
inferred← citeshttps://doi.org/10.1128/jcm.01243-20openalex-snapshot
Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2
inferred← citeshttps://doi.org/10.1128/jcm.02204-20openalex-snapshot
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
inferred← citeshttps://doi.org/10.1128/mbio.03495-21openalex-snapshot
Great Expectations of COVID-19 Herd Immunity
inferred← citeshttps://doi.org/10.1128/msphere.00224-21openalex-snapshot
Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts
inferred← citeshttps://doi.org/10.1128/msphere.00344-20openalex-snapshot
COVID-19: an Immunopathological View
inferred← citeshttps://doi.org/10.1128/spectrum.04220-23openalex-snapshot
Seasonal human coronaviruses OC43, 229E, and NL63 induce cell surface modulation of entry receptors and display host cell-specific viral replication kinetics
inferred← citeshttps://doi.org/10.1136/bmjgh-2020-003098openalex-snapshot
The COVID-19 pandemic: diverse contexts; different epidemics—how and why?
inferred← citeshttps://doi.org/10.1155/2021/8160860openalex-snapshot
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome‐Corona Virus‐2 (SARS‐CoV‐2)
inferred← citeshttps://doi.org/10.1172/jci144115openalex-snapshot
Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity
inferred← citeshttps://doi.org/10.1172/jci144807openalex-snapshot
Does common cold coronavirus infection protect against severe SARS-CoV-2 disease?
inferred← citeshttps://doi.org/10.1177/03946320221115316openalex-snapshot
COVID-19: Clinical laboratory diagnosis and monitoring of novel coronavirus infected patients using molecular, serological and biochemical markers: A review
inferred← citeshttps://doi.org/10.1177/19458924241276274openalex-snapshot
Common Cold Coronavirus 229E Induces Higher Interferon Stimulating Gene Responses in Human Nasal Epithelial Cells from Patients with Chronic Rhinosinusitis with Polyposis
inferred← citeshttps://doi.org/10.1183/13993003.01852-2020openalex-snapshot
What do differences in case fatality ratios between children and adults tell us about COVID-19?
inferred← citeshttps://doi.org/10.1186/1471-2334-13-433openalex-snapshot
First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood
inferred← citeshttps://doi.org/10.1186/s12879-021-06258-6openalex-snapshot
Seroprevalence of human coronaviruses among patients visiting hospital-based sentinel sites in Uganda
inferred← citeshttps://doi.org/10.1371/journal.pbio.3001265openalex-snapshot
The landscape of antibody binding in SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1371/journal.pone.0251587openalex-snapshot
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
inferred← citeshttps://doi.org/10.1371/journal.pone.0325923openalex-snapshot
Detectable SARS-CoV-2 specific immune responses in recovered unvaccinated individuals 250 days post wild type infection
inferred← citeshttps://doi.org/10.1515/cclm-2020-0722openalex-snapshot
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
inferred← citeshttps://doi.org/10.15789/2220-7619-fct-15641openalex-snapshot
From coronaviruses to coronaviruses
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2394537/v1openalex-snapshot
Knowledge and Practical Attitudes of Caregivers Regarding Covid-19 at Sikasso Hospital in Mali in 2022
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2394537/v2openalex-snapshot
Practical Knowledge and Attitudes of Caregivers Faced With COVID-19 at Sikasso Hospital - Mali
inferred← citeshttps://doi.org/10.21203/rs.3.rs-291307/v1openalex-snapshot
Seroprevalence of Human Coronaviruses Among Patients Visiting Hospital-Based Sentinel Sites in Uganda
inferred← citeshttps://doi.org/10.21203/rs.3.rs-34571/v1openalex-snapshot
Using prenatal blood samples to validate COVID-19 rapid serologic tests
inferred← citeshttps://doi.org/10.2807/1560-7917.es.2020.25.16.2000421openalex-snapshot
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
inferred← citeshttps://doi.org/10.3389/fcimb.2020.605334openalex-snapshot
Is the “Common Cold” Our Greatest Ally in the Battle Against SARS-CoV-2?
inferred← citeshttps://doi.org/10.3389/fcimb.2022.978440openalex-snapshot
Pre-existing anti-HCoV-OC43 immunity influences the durability and cross-reactivity of humoral response to SARS-CoV-2 vaccination
inferred← citeshttps://doi.org/10.3389/fendo.2022.798975openalex-snapshot
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
inferred← citeshttps://doi.org/10.3389/fimmu.2020.567710openalex-snapshot
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
inferred← citeshttps://doi.org/10.3389/fimmu.2020.591897openalex-snapshot
As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention
inferred← citeshttps://doi.org/10.3389/fimmu.2020.607918openalex-snapshot
HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients
inferred← citeshttps://doi.org/10.3389/fimmu.2020.610688openalex-snapshot
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
inferred← citeshttps://doi.org/10.3389/fimmu.2021.635942openalex-snapshot
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity
inferred← citeshttps://doi.org/10.3389/fimmu.2021.790415openalex-snapshot
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide
inferred← citeshttps://doi.org/10.3389/fimmu.2022.1042406openalex-snapshot
Pre-existing humoral immunity to low pathogenic human coronaviruses exhibits limited cross-reactive antibodies response against SARS-CoV-2 in children
inferred← citeshttps://doi.org/10.3389/fimmu.2022.800070openalex-snapshot
Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2
inferred← citeshttps://doi.org/10.3389/fimmu.2022.889836openalex-snapshot
Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity
inferred← citeshttps://doi.org/10.3389/fimmu.2022.904686openalex-snapshot
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.3389/fimmu.2022.954093openalex-snapshot
Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1195533openalex-snapshot
Effect of seasonal coronavirus immune imprinting on the immunogenicity of inactivated COVID-19 vaccination
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1291048openalex-snapshot
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1425374openalex-snapshot
Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1576430openalex-snapshot
Evaluation of humoral and cellular immune responses in healthcare workers with varying levels of SARS-CoV-2 exposure: effects of CoronaVac vaccination followed by heterologous booster
inferred← citeshttps://doi.org/10.3389/fmed.2020.594439openalex-snapshot
Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses
inferred← citeshttps://doi.org/10.3389/fmicb.2022.853410openalex-snapshot
Atypical Antibody Dynamics During Human Coronavirus HKU1 Infections
inferred← citeshttps://doi.org/10.3389/fped.2020.595539openalex-snapshot
Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis?
inferred← citeshttps://doi.org/10.3390/antib12040082openalex-snapshot
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Siberian Populations
inferred← citeshttps://doi.org/10.3390/biomedicines12030564openalex-snapshot
The Influence of Cross-Reactive T Cells in COVID-19
inferred← citeshttps://doi.org/10.3390/ijms26136041openalex-snapshot
Similarity to Self-Antigens Shapes Epitope Recognition from Viruses Under Autoimmune and Infectious Disease
inferred← citeshttps://doi.org/10.3390/microbiolres14030093openalex-snapshot
The Influence of Pre-Existing Immunity against Human Common Cold Coronaviruses on COVID-19 Susceptibility and Severity
inferred← citeshttps://doi.org/10.3390/microorganisms9081643openalex-snapshot
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study
inferred← citeshttps://doi.org/10.3390/v11010043openalex-snapshot
Development of a Whole-Virus ELISA for Serological Evaluation of Domestic Livestock as Possible Hosts of Human Coronavirus NL63
inferred← citeshttps://doi.org/10.3390/v13050854openalex-snapshot
Will SARS-CoV-2 Become Just Another Seasonal Coronavirus?
inferred← citeshttps://doi.org/10.3390/v13071244openalex-snapshot
Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
inferred← citeshttps://doi.org/10.3390/v13102075openalex-snapshot
Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43
inferred← citeshttps://doi.org/10.3390/v13122553openalex-snapshot
Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons
inferred← citeshttps://doi.org/10.3390/v15020303openalex-snapshot
The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
inferred← citeshttps://doi.org/10.3390/v15030627openalex-snapshot
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination
inferred← citeshttps://doi.org/10.3390/vaccines10060904openalex-snapshot
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
inferred← citeshttps://doi.org/10.3390/vaccines11020408openalex-snapshot
Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
inferred← citeshttps://doi.org/10.3390/vaccines11091403openalex-snapshot
Detection of Antibodies against Endemic and SARS-CoV-2 Coronaviruses with Short Peptide Epitopes
inferred← citeshttps://doi.org/10.3390/vaccines9060611openalex-snapshot
Characterization of Immune Responses to SARS-CoV-2 and Other Human Pathogenic Coronaviruses Using a Multiplex Bead-Based Immunoassay
inferred← citeshttps://doi.org/10.3399/bjgp21x715169openalex-snapshot
The role of antibody tests for COVID-19 in primary care
inferred← citeshttps://doi.org/10.36233/0507-4088-2020-65-5-3openalex-snapshot
Analysis of human coronaviruses circulation
inferred← citeshttps://doi.org/10.37201/202006openalex-snapshot
inferred← citeshttps://doi.org/10.37201/req/086.2020openalex-snapshot
Immunity against SARS-CoV-2: walking to the vaccination
inferred← citeshttps://doi.org/10.3947/ic.2020.52.2.154openalex-snapshot
Age-Related Morbidity and Mortality among Patients with COVID-19
inferred← citeshttps://doi.org/10.4049/jimmunol.2000767openalex-snapshot
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19
inferred← citeshttps://doi.org/10.4049/jimmunol.2000839openalex-snapshot
Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns
inferred← citeshttps://doi.org/10.4102/ajlm.v12i1.1964openalex-snapshot
The COVID-19 pandemic in sub-Saharan Africa: The significance of presumed immune sufficiency
inferred← citeshttps://doi.org/10.4110/in.2021.21.e4openalex-snapshot
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages
inferred← citeshttps://doi.org/10.47832/2717-8234.11.4openalex-snapshot
IMMUNOLOGICAL RESPONSE TO SARS-COV 2 AND IMMUNOPATHOLOGY OF COVID-19 INFECTION
inferred← citeshttps://doi.org/10.70675/00bd0a63z263fz470az876czb50b49ba4313openalex-snapshot
Caractérisation de la réponse lymphocytaire B mémoire contre le SARS-CoV-2 après infection ou vaccination
inferred← citeshttps://doi.org/10.70675/6b8b8b92zda75z46a0z98e6zc9f888cb9715openalex-snapshot
T immune responses to SARS-CoV-2 : identification of the immunogenic region associated with protection against infection
inferred← citeshttps://doi.org/10.7705/biomedica.7168openalex-snapshot
HCoV-NL63 and HCoV-HKU1 seroprevalence and its relationship with the clinical features of COVID-19 patients from Villavicencio, Colombia
inferred← citeshttps://doi.org/10.7883/yoken.jjid.2021.250openalex-snapshot
Clinical Evaluation of Conventional Human Coronavirus Infection in Adults
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.